Assenagon Asset Management S.A. Neurocrine Biosciences Inc Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 60,227 shares of NBIX stock, worth $8.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60,227
Previous 393,455
84.69%
Holding current value
$8.46 Million
Previous $43.5 Million
82.61%
% of portfolio
0.01%
Previous 0.08%
Shares
22 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.99 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.38 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$782 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$628 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$433 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...